Search for: "Novartis Pharmaceuticals Inc"
Results 361 - 380
of 394
Sorted by Relevance
|
Sort by Date
11 Sep 2012, 11:36 am
Novartis Pharmaceutical Corp. [read post]
7 Jun 2007, 1:17 am
The lawsuit says Christopher Woods sought treatment for the condition, called severe priapism, the day after he bought the nutrition beverage made by the pharmaceutical company Novartis AG at a drugstore and drank it. [read post]
25 Nov 2008, 5:04 am
Novartis Consumer Health, Inc., ___ F. [read post]
19 Mar 2015, 5:00 am
Novartis AG, ___ F. [read post]
9 Aug 2008, 1:50 am
: (Techdirt), Microsoft Research launches new tools for knowledge sharing: (creativecommons.org), Yet another star singer, Duffy, doesn’t mind file-sharing: (Techdirt) Events 20 August – Bill Patry speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry speaking on copyright – Sydney:… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]
12 Dec 2021, 2:22 pm
Novartis Pharms. [read post]
26 May 2011, 10:54 am
Novartis Pharmaceuticals Corp., 2010 WL 1463035, at *1 (D.N.J. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
5 Jan 2011, 9:22 am
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010. [read post]
3 Aug 2020, 7:02 am
Where there are specialists with a focus on the kind of work with which a patent is concerned, they are the relevant addressees of the patent and their specialist skills are attributed to the notional skilled person, even if the patent might also be of a broader application and of interest to non-specialists (Medimmune Ltd v Novartis Pharmaceuticals UK Ltd [2013] RPC 27). [read post]
12 Jan 2010, 5:00 am
Novartis Pharmaceuticals Corp., No. [read post]
17 Oct 2015, 5:29 am
Novartis Pharms., No. 5:11–CV–680–D, 2013 WL 4854488, at *3 (Sept. 11, 2013). [read post]
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
10 Oct 2008, 3:22 pm
As a result of litigating medical device and pharmaceutical cases Attorney Fulmer has observed that in the past, scientists and inventors discovered something new and then developed companies around the discovery to serve the consumer. [read post]
27 Sep 2007, 11:38 am
Novartis Corp., 378 F. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
